Will the Long-Named Perfluorohexyloctane Produce Long-lasting Improvements in Patients With Meibomian Gland Disease?

  • Seitzman, Gerami D. MD
  • Lietman, Thomas M. MD

  • 1Francis I. Proctor Foundation, San Francisco, California

    2Department of Ophthalmology, University of California, San Francisco

Article Information

Corresponding Author: Gerami D. Seitzman, University of California, San Francisco, 490 Illinois St, San Francisco, CA 94158 ([email protected]).

Published Online: March 16, 2023. doi:10.1001/jamaophthalmol.2023.0399

Conflict of Interest Disclosures: Dr Seitzman reported consultation for Dompé Pharmaceuticals, outside the submitted work. No other disclosures were reported.

Received January 27, 2023

Accepted January 27, 2023

JAMA Ophthalmology Publish Ahead of Print, April 2023. | DOI: 10.1001/jamaophthalmol.2023.0399

Corresponding Article

Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients

A Randomized Clinical Trial

  • Tian, Lei MD
  • Gao, Zuojun MM
  • Zhu, Lei MD
  • Shi, Xiaoru MD
  • Zhao, Shaozhen MD
  • Gu, Hao MM
  • Xu, Guoxing MM
  • Wang, Linnong MM
  • Dai, Hong MB
  • Zhang, Hong MD
  • Jin, Xiuming MD
  • Ma, Ke MD
  • Xu, Yonggen MD
  • Ma, Lixiao MB
  • Pei, Cheng MD
  • Ke, Bilian MD
  • Krösser, Sonja PhD
  • Zhang, Yunxia MM
  • Jie, Ying MD
JAMA Ophthalmology Publish Ahead of Print, April 2023. | DOI: 10.1001/jamaophthalmol.2023.0270
Copyright © 2023 by the American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. American Medical Association, 515 N. State St, Chicago, IL 60610.
View full text|Download PDF